基质诱导的自体软骨细胞植入(mACI)与自体基质诱导的软骨形成(AMIC)治疗膝关节软骨缺损:系统综述。

IF 6.7 2区 医学 Q1 Medicine
Filippo Migliorini, Jörg Eschweiler, Christian Götze, Arne Driessen, Markus Tingart, Nicola Maffulli
{"title":"基质诱导的自体软骨细胞植入(mACI)与自体基质诱导的软骨形成(AMIC)治疗膝关节软骨缺损:系统综述。","authors":"Filippo Migliorini,&nbsp;Jörg Eschweiler,&nbsp;Christian Götze,&nbsp;Arne Driessen,&nbsp;Markus Tingart,&nbsp;Nicola Maffulli","doi":"10.1093/bmb/ldac004","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chondral defects of the knee are common and their treatment is challenging.</p><p><strong>Source of data: </strong>PubMed, Google scholar, Embase and Scopus databases.</p><p><strong>Areas of agreement: </strong>Both autologous matrix-induced chondrogenesis (AMIC) and membrane-induced autologous chondrocyte implantation (mACI) have been used to manage chondral defects of the knee.</p><p><strong>Areas of controversy: </strong>It is debated whether AMIC and mACI provide equivalent outcomes for the management of chondral defects in the knee at midterm follow-up. Despite the large number of clinical studies, the optimal treatment is still controversial.</p><p><strong>Growing points: </strong>To investigate whether AMIC provide superior outcomes than mACI at midterm follow-up.</p><p><strong>Areas timely for developing research: </strong>AMIC may provide better outcomes than mACI for chondral defects of the knee. Further studies are required to verify these results in a clinical setting.</p>","PeriodicalId":9280,"journal":{"name":"British medical bulletin","volume":"141 1","pages":"47-59"},"PeriodicalIF":6.7000,"publicationDate":"2022-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351375/pdf/","citationCount":"6","resultStr":"{\"title\":\"Matrix-induced autologous chondrocyte implantation (mACI) versus autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the knee: a systematic review.\",\"authors\":\"Filippo Migliorini,&nbsp;Jörg Eschweiler,&nbsp;Christian Götze,&nbsp;Arne Driessen,&nbsp;Markus Tingart,&nbsp;Nicola Maffulli\",\"doi\":\"10.1093/bmb/ldac004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Chondral defects of the knee are common and their treatment is challenging.</p><p><strong>Source of data: </strong>PubMed, Google scholar, Embase and Scopus databases.</p><p><strong>Areas of agreement: </strong>Both autologous matrix-induced chondrogenesis (AMIC) and membrane-induced autologous chondrocyte implantation (mACI) have been used to manage chondral defects of the knee.</p><p><strong>Areas of controversy: </strong>It is debated whether AMIC and mACI provide equivalent outcomes for the management of chondral defects in the knee at midterm follow-up. Despite the large number of clinical studies, the optimal treatment is still controversial.</p><p><strong>Growing points: </strong>To investigate whether AMIC provide superior outcomes than mACI at midterm follow-up.</p><p><strong>Areas timely for developing research: </strong>AMIC may provide better outcomes than mACI for chondral defects of the knee. Further studies are required to verify these results in a clinical setting.</p>\",\"PeriodicalId\":9280,\"journal\":{\"name\":\"British medical bulletin\",\"volume\":\"141 1\",\"pages\":\"47-59\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2022-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351375/pdf/\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British medical bulletin\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/bmb/ldac004\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British medical bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/bmb/ldac004","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 6

摘要

膝关节软骨缺损是常见的,其治疗具有挑战性。数据来源:PubMed, Google scholar, Embase和Scopus数据库。一致领域:自体基质诱导的软骨形成(AMIC)和膜诱导的自体软骨细胞植入(mACI)已被用于膝关节软骨缺损的治疗。争议领域:在中期随访中,对于膝关节软骨缺损的治疗,AMIC和mACI是否提供了相同的结果,这是有争议的。尽管有大量的临床研究,但最佳治疗方法仍存在争议。生长点:探讨中期随访时AMIC是否优于mACI。及时开展研究的领域:对于膝关节软骨缺损,AMIC可能比mACI提供更好的结果。需要进一步的研究在临床环境中验证这些结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Matrix-induced autologous chondrocyte implantation (mACI) versus autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the knee: a systematic review.

Matrix-induced autologous chondrocyte implantation (mACI) versus autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the knee: a systematic review.

Matrix-induced autologous chondrocyte implantation (mACI) versus autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the knee: a systematic review.

Introduction: Chondral defects of the knee are common and their treatment is challenging.

Source of data: PubMed, Google scholar, Embase and Scopus databases.

Areas of agreement: Both autologous matrix-induced chondrogenesis (AMIC) and membrane-induced autologous chondrocyte implantation (mACI) have been used to manage chondral defects of the knee.

Areas of controversy: It is debated whether AMIC and mACI provide equivalent outcomes for the management of chondral defects in the knee at midterm follow-up. Despite the large number of clinical studies, the optimal treatment is still controversial.

Growing points: To investigate whether AMIC provide superior outcomes than mACI at midterm follow-up.

Areas timely for developing research: AMIC may provide better outcomes than mACI for chondral defects of the knee. Further studies are required to verify these results in a clinical setting.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
British medical bulletin
British medical bulletin 医学-医学:内科
CiteScore
13.10
自引率
1.50%
发文量
24
审稿时长
>12 weeks
期刊介绍: British Medical Bulletin is a multidisciplinary publication, which comprises high quality reviews aimed at generalist physicians, junior doctors, and medical students in both developed and developing countries. Its key aims are to provide interpretations of growing points in medicine by trusted experts in the field, and to assist practitioners in incorporating not just evidence but new conceptual ways of thinking into their practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信